Nell Greenfieldboyce

Nell Greenfieldboyce is a NPR science correspondent.

With reporting focused on general science, NASA, and the intersection between technology and society, Greenfieldboyce has been on the science desk's technology beat since she joined NPR in 2005.

In that time Greenfieldboyce has reported on topics including the narwhals in Greenland, the ending of the space shuttle program, and the reasons why independent truckers don't want electronic tracking in their cabs.

Much of Greenfieldboyce's reporting reflects an interest in discovering how applied science and technology connects with people and culture. She has worked on stories spanning issues such as pet cloning, gene therapy, ballistics, and federal regulation of new technology.

Prior to NPR, Greenfieldboyce spent a decade working in print, mostly magazines including U.S. News & World Report and New Scientist.

A graduate of Johns Hopkins, earning her Bachelor's of Arts degree in social sciences and a Master's of Arts degree in science writing, Greenfieldboyce taught science writing for four years at the university. She was honored for her talents with the Evert Clark/Seth Payne Award for Young Science Journalists.

One of the reasons Ebola is so terrifying is that there's no vaccine and no cure. But the World Health Organization hopes to change that, with plans to quickly test experimental products during this outbreak.

By November, two promising vaccines will have been tested on people to see if they're safe, says Marie-Paule Kieny, assistant director-general at WHO.

A smoldering debate about whether researchers should ever deliberately create superflu strains and other risky germs in the interest of science has flared once again.

No one likes it when a new drug in people's medicine cabinets turns out to have problems — just remember the Vioxx debacle a decade ago, when the painkiller was removed from the market over concerns that it increased the risk of heart attack and stroke.

To do a better job of spotting unforeseen risks and side effects, the Food and Drug Administration is trying something new — and there's a decent chance that it involves your medical records.

The electric eel's powerful ability to deliver deadly shocks — up to 600 volts — makes it the most famous electric fish, but hundreds of other species produce weaker electric fields. Now, a new genetic study of electric fish has revealed the surprising way they got electrified.

Scientists have long puzzled over the origin and evolution of our closest relative, the Neanderthal. Now, researchers say Neanderthals seem to have developed their distinctive jaws and other facial features first, before they evolved to have big brains.

That's according to an analysis of 17 skulls, all taken from one excavation site in a mountain cave in Atapuerca, Spain, known as the Sima de los Huesos — the "pit of bones."

Octopus arms keep from getting all tangled up in part because some kind of chemical in octopus skin prevents the tentacles' suckers from grabbing on.

That was the surprise discovery of scientists who were trying to understand how octopuses manage to move all their weird appendages without getting tied in knots.

Unlike humans, octopuses don't have a constant awareness of their arms' locations. It's kind of like the eight arms have minds of their own. And as an octopus arm travels through the water, its neighboring arms are constantly in reach.

For the first time, scientists have expanded life's genetic alphabet, by inserting two unnatural, man-made "letters" into a bacterium's DNA, and by showing that the cell's machinery can copy them.

The advance means that scientists have a new tool for exploring how life encodes information, which could help them understand life's origins.

What's more, this is a step towards giving living cells new abilities, like being able to make more and better medicines, cheaper and faster.

Questions are swirling around a science journal's decision last year to publish a description of a newly discovered botulinum toxin while omitting key genetic details that researchers would normally disclose.

The unusual case highlights important unresolved issues in how to balance scientific openness with the worry that biological information could potentially be misused.

Scientists who have been hunting for another Earth beyond our solar system have come across a planet that's remarkably similar to our world.

It's almost the same size as Earth, and it orbits in its star's "Goldilocks zone" — where temperatures are not too hot, not too cold, and maybe just right for life.

But a lot about this planet is going to remain a mystery, because it's 500 light-years away.

The Dutch virologist accused of engineering a dangerous superflu a few years ago is back with more contentious research.

In 2011, Ron Fouchier and his team at Erasmus Medical Center took the H5N1 flu virus and made it more contagious. Now the team has published another study with more details on the exact genetic changes needed to do the trick.

NASA is hoping to soon venture out farther into space than ever before. But these long journeys mean astronauts could face greater risks to their physical and mental health than the space agency currently allows.

Now, an independent group of experts convened by the Institute of Medicine, the health arm of the National Academy of Sciences, has weighed in on how NASA should make decisions about the kinds of risks that are acceptable for missions that venture outside low Earth orbit or extend beyond 30 days.

Scientists have spotted a new dwarf planet at the edge of our solar system. It's a kind of pink ice ball that's way out there, far beyond Pluto.

Astronomers used to think this region of space was a no man's land. But the new findings suggest that it holds many small worlds — and there are even hints of an unseen planet bigger than Earth.

More than 30 years ago, Robert Farquhar stole a spacecraft.

Now he's trying to give it back.

The green satellite, covered with solar panels, is hurtling back toward the general vicinity of Earth, after nearly three decades of traveling in a large, looping orbit around the sun.

A huge amount of ancient helium is rising up from the rocks beneath Yellowstone National Park — about enough to fill up a Goodyear blimp every week.

The gas comes from a vast store of helium that's accumulated in the Earth's crust for hundreds of millions of years, scientists report in the journal Nature this week.

The National Institutes of Health is teaming up with major drug companies in a new effort to identify disease-related molecules and biological processes that could lead to future medicines.

The public-private partnership is called AMP, for the "Accelerating Medicines Partnership," and it will focus first on Alzheimer's disease, Type 2 diabetes, and two autoimmune disorders: rheumatoid arthritis and lupus.

Pages